AMPH: Amphastar Pharmaceuticals, Inc.
About
Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
Current Value
$43.711 Year Return
Current Value
$43.711 Year Return
Key Details
Market Cap
$2.10B
P/E Ratio
14.51
1Y Stock Return
-23.00%
1Y Revenue Growth
20.33%
Dividend Yield
0.00%
Price to Book
2.9
Strategies that include AMPH
Stock's related to AMPH
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| XMTR | 48.54% | $1.48B | +50.13% | 0.00% |
| XRAY | 47.94% | $3.75B | -39.08% | 3.32% |
| KVYO | 45.23% | $9.29B | +24.95% | 0.00% |
| APPS | 43.81% | $125.51M | -75.85% | 0.00% |
| FA | 42.30% | $3.04B | +17.64% | 0.00% |
| AMAL | 42.25% | $1.08B | +69.89% | 1.30% |
| FC | 40.71% | $468.04M | -10.51% | 0.00% |
| MATV | 40.31% | $678.65M | -4.95% | 3.16% |
| WOLF | 39.87% | $822.47M | -80.83% | 0.00% |
| CLPT | 39.67% | $302.60M | +84.68% | 0.00% |
| SBSI | 39.05% | $1.07B | +25.26% | 4.11% |
| RGNX | 38.95% | $473.65M | -51.96% | 0.00% |
| CHCO | 38.74% | $1.89B | +32.97% | 2.29% |
| MBWM | 38.45% | $783.85M | +39.14% | 2.90% |
| GLRE | 37.82% | $510.30M | +29.88% | 0.00% |
| KELYA | 37.79% | $504.23M | -32.54% | 2.14% |
| ALTO | 37.54% | $106.54M | -39.83% | 0.00% |
| ALEX | 37.47% | $1.41B | +18.14% | 4.59% |
| FRST | 37.42% | $302.36M | +21.93% | 3.29% |
| SDGR | 37.04% | $1.38B | -35.46% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| AAPL | 0.04% | $3.45T | +19.74% | 0.43% |
| ZH | 0.09% | $333.09M | -40.59% | 0.00% |
| PRA | -0.10% | $830.78M | +27.17% | 0.00% |
| SRAD | 0.10% | $5.18B | +75.20% | 0.00% |
| LUMN | -0.10% | $7.85B | +486.36% | 0.00% |
| KEP | -0.11% | $11.16B | +25.58% | 0.00% |
| PG | -0.12% | $402.15B | +14.14% | 2.33% |
| AGNC | -0.16% | $8.56B | +9.64% | 14.95% |
| IMMP | 0.24% | $293.82M | +8.31% | 0.00% |
| INSM | -0.26% | $13.19B | +202.50% | 0.00% |
| FTNT | 0.31% | $69.59B | +72.67% | 0.00% |
| GOOGL | -0.37% | $2.18T | +30.04% | 0.23% |
| GOOG | -0.39% | $2.20T | +29.55% | 0.22% |
| PSQH | -0.43% | $79.26M | -57.46% | 0.00% |
| ENV | -0.52% | $3.49B | +69.46% | 0.00% |
| LLYVK | 0.54% | $6.24B | +94.65% | 0.00% |
| NTNX | -0.62% | $18.33B | +70.72% | 0.00% |
| FAT | -0.71% | $89.30M | -11.53% | 10.73% |
| TXO | 0.71% | $737.26M | -1.80% | 13.22% |
| T | -0.74% | $163.09B | +40.40% | 4.87% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| BROS | -19.47% | $5.67B | +74.77% | 0.00% |
| MNST | -15.34% | $52.25B | -1.95% | 0.00% |
| TCTM | -13.40% | $8.10M | -42.99% | 0.00% |
| FRSH | -12.52% | $4.39B | -20.05% | 0.00% |
| KODK | -12.29% | $422.90M | +41.40% | 0.00% |
| WOW | -12.02% | $434.90M | +18.48% | 0.00% |
| WWW | -11.82% | $1.79B | +171.57% | 1.80% |
| VERX | -11.57% | $7.99B | +89.70% | 0.00% |
| GFI | -11.50% | $13.42B | +10.06% | 2.63% |
| HRL | -11.40% | $16.30B | -8.38% | 3.81% |
| PSTG | -10.55% | $16.35B | +36.41% | 0.00% |
| CDLX | -10.26% | $178.39M | -54.00% | 0.00% |
| APP | -9.85% | $107.79B | +728.45% | 0.00% |
| UMH | -9.38% | $1.54B | +39.30% | 4.39% |
| SCKT | -8.92% | $10.88M | +15.32% | 0.00% |
| PETS | -8.28% | $93.60M | -41.21% | 0.00% |
| HAE | -8.02% | $4.26B | +2.89% | 0.00% |
| SONY | -7.87% | $114.13B | +9.00% | 1.49% |
| MCK | -7.85% | $78.15B | +35.51% | 0.42% |
| BMBL | -7.20% | $845.98M | -43.90% | 0.00% |
ETF's related to AMPH
Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| XPH | 47.10% | $157.87M | 0.35% |
| SMMV | 45.47% | $321.07M | 0.2% |
| IJT | 42.88% | $6.64B | 0.18% |
| RSPA | 42.77% | $273.87M | 0% |
| PSC | 42.52% | $702.17M | 0.38% |
| XSMO | 42.16% | $1.25B | 0.39% |
| FXH | 42.16% | $1.15B | 0.62% |
| SLYG | 41.97% | $3.69B | 0.15% |
| IBB | 41.77% | $6.66B | 0.45% |
| GSSC | 41.54% | $529.86M | 0.2% |
| IJR | 41.28% | $90.05B | 0.06% |
| IWC | 41.27% | $933.99M | 0.6% |
| XSLV | 41.24% | $322.27M | 0.25% |
| VTWO | 41.10% | $12.38B | 0.1% |
| FSMD | 41.09% | $583.89M | 0.15% |
| PRFZ | 41.03% | $2.65B | 0.39% |
| SPSM | 40.91% | $12.72B | 0.03% |
| DFAT | 40.78% | $11.16B | 0.28% |
| IWM | 40.69% | $75.73B | 0.19% |
| IWN | 40.69% | $13.17B | 0.24% |
Uncorrelated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GSG | 0.04% | $914.42M | 0.75% |
| FBND | -0.06% | $15.84B | 0.36% |
| NEAR | -0.11% | $2.91B | 0.25% |
| DBO | 0.17% | $217.57M | 0.77% |
| JCPB | -0.19% | $4.55B | 0.38% |
| IUSB | 0.21% | $31.77B | 0.06% |
| AGZD | 0.22% | $142.76M | 0.23% |
| SPAB | -0.24% | $8.19B | 0.03% |
| SHAG | 0.26% | $33.13M | 0.12% |
| LMBS | -0.26% | $4.62B | 0.64% |
| CGCB | 0.26% | $1.49B | 0.27% |
| IBTF | -0.33% | $2.05B | 0.07% |
| IBDR | 0.38% | $2.93B | 0.1% |
| ICSH | -0.39% | $5.57B | 0.08% |
| FISR | 0.39% | $307.49M | 0.5% |
| UITB | -0.42% | $2.36B | 0.38% |
| BNDW | -0.46% | $854.64M | 0.05% |
| NUAG | -0.50% | $37.49M | 0.21% |
| BSCT | 0.50% | $1.42B | 0.1% |
| COMT | 0.52% | $829.06M | 0.48% |
Inversely Correlated ETFs
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| BTAL | -22.02% | $388.04M | 1.43% |
| TAIL | -18.66% | $67.98M | 0.59% |
| DBA | -16.23% | $755.88M | 0.93% |
| IBTE | -14.36% | $1.70B | 0.07% |
| HIGH | -12.95% | $302.78M | 0.51% |
| FTSM | -12.70% | $6.08B | 0.45% |
| VIXY | -12.32% | $195.31M | 0.85% |
| USCI | -12.23% | $185.47M | 1.07% |
| DFSD | -11.74% | $3.63B | 0.16% |
| SCHP | -11.43% | $11.70B | 0.03% |
| SCHQ | -11.20% | $762.08M | 0.03% |
| LGOV | -11.15% | $607.48M | 0.67% |
| GOVZ | -11.14% | $313.00M | 0.1% |
| LTPZ | -11.11% | $715.65M | 0.2% |
| WEAT | -10.82% | $120.27M | 0.28% |
| PWZ | -10.69% | $697.36M | 0.28% |
| CGSM | -10.35% | $514.53M | 0.25% |
| TPMN | -10.33% | $40.60M | 0.65% |
| UUP | -9.66% | $309.25M | 0.77% |
| FMHI | -9.48% | $747.15M | 0.7% |
News
Finnhub
RANCHO CUCAMONGA - Amphastar Pharmaceuticals, Inc. announced today that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside...
Yahoo
Amphastar Pharmaceuticals ( NASDAQ:AMPH ) Third Quarter 2024 Results Key Financial Results Revenue: US$191.2m (up 5.9...
Yahoo
Q3 2024 Amphastar Pharmaceuticals Inc Earnings Call
Finnhub
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION ...
Yahoo
Amphastar Pharmaceuticals Inc (AMPH) reports a 6% revenue increase, driven by record Primatene Mist sales, despite facing competitive and logistical hurdles.
Yahoo
Although the revenue and EPS for Amphastar (AMPH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.